Persistent Helicobacter pylori Infection After a Course of Antimicrobial Therapy—What's Next?
published online 18 July 2008.
A 35-year-old Hispanic woman with no significant past medical history presents to the emergency department at midnight with a 3-month history of intermittent epigastric pain culminating in 3 episodes of coffee-ground emesis on the day of presentation. Her blood pressure is 90/60 mm Hg and her pulse is 95 beats per minute with evidence of postural orthostasis. Nasogastric lavage reveals coffee-ground material, which clears with a liter of saline. Her hematocrit is 32% before hydration. She is stabilized and resuscitated with intravenous fluids. Upper endoscopy reveals a 1-cm, clean-based, duodenal bulb ulcer. Gastric biopsies reveal a negative rapid urease test but histology reveals active gastritis and Helicobacter pylori (H pylori) organisms. On discharge the following morning she is instructed to take a proton pump inhibitor (PPI), amoxicillin 1 g, and clarithromycin 500 mg twice daily for 7 days. The patient returns to her primary care physician 4 weeks later, reporting initial symptom improvement followed by a gradual recurrence of her epigastric pain. The primary care physician orders a serology test that is positive for H pylori. This is followed by a course of PPI, amoxicillin 1 g, and clarithromycin 500 mg given twice daily for 14 days. The patient returns to her primary care physician 3 months later reporting persistent dyspepsia. She is referred to a gastroenterologist for her persistent symptoms. An esophagogastroduodenoscopy is performed, revealing erosive gastropathy with mucosal biopsy specimens confirming persistent gastritis and H pylori organisms.
⁎Division of Gastroenterology, Department of Medicine, University of Michigan Medical Center, Ann Arbor, Michigan
‡GI Physiology Laboratory, University of Michigan Medical Center, Ann Arbor, Michigan
Address requests for reprints to: William D. Chey, MD, AGAF, FACG, FACP, Professor of Internal Medicine, Director, GI Physiology Laboratory, University of Michigan Medical Center, 3912 Taubman Center, Box 0362, Ann Arbor, Michigan 48109. fax: (734) 936-7392
Dr Chey is on the speaker's bureau and is a consultant for Santarus, TAP Pharmaceuticals, and Takeda.